inclisiran 284 MG in 1.5 ML Prefilled Syringe
- RxCUI
- 2588263
- RxNorm name
- inclisiran 284 MG in 1.5 ML Prefilled Syringe
- Display name
- inclisiran 284 MG in 1.5 ML Prefilled Syringe
- Full name
- inclisiran 284 MG in 1.5 ML Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEQVIO | INCLISIRAN | Novartis Pharmaceuticals Corporation | 6fc0afca-4513-4c35-b594-6544aee29a44 | 2026-02-12 | Warnings, Adverse reactions | 2588263 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6fc0afca-4513-4c35-b594-6544aee29a44 | inclisiran 284 MG in 1.5 ML Prefilled Syringe | PSN | 12 | These highlights do not include all the information needed to use LEQVIO safely and effectively. See full prescribing information for LEQVIO. LEQVIO ® (inclisiran) injection, for subcutaneous use Initial U.S. Approval: 2021 | 20260212 |
| 6fc0afca-4513-4c35-b594-6544aee29a44 | 1.5 ML inclisiran 189 MG/ML Prefilled Syringe | SCD | 12 | These highlights do not include all the information needed to use LEQVIO safely and effectively. See full prescribing information for LEQVIO. LEQVIO ® (inclisiran) injection, for subcutaneous use Initial U.S. Approval: 2021 | 20260212 |
| 6fc0afca-4513-4c35-b594-6544aee29a44 | inclisiran 284 MG per 1.5 ML Prefilled Syringe | SY | 12 | These highlights do not include all the information needed to use LEQVIO safely and effectively. See full prescribing information for LEQVIO. LEQVIO ® (inclisiran) injection, for subcutaneous use Initial U.S. Approval: 2021 | 20260212 |